Research Advances and Clinical Impact of New Data From Crohn’s & Colitis Congress® 2019

Download All
February 7-9, 2019; Las Vegas, Nevada
Review expert commentary of key data from the 2019 Crohn’s and Colitis Congress
Baldeep S. Pabla, MD, MSCI
D. Brent Polk, MD, AGAF
David A. Schwartz, MD, FACG, AGAF

ClinicalThought

How might IBD disease activity and drug monitoring affect our approach to treatment? Here’s my take.

D. Brent Polk, MD, AGAF Released: June 7, 2019

We highlight our thoughts on the most recent data for 3 new and emerging IBD treatments.

Baldeep S. Pabla, MD, MSCI David A. Schwartz, MD, FACG, AGAF Released: June 26, 2019
Produced in collaboration with
Supported by educational grants from
Celgene
Takeda Pharmaceuticals USA, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue